Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 6.99 · gapped below the open, then crossed back over prior close. High/low 7.13 at 11:30 am ET, 6.84 at 4:00 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Effective April 1, 2025, the Company entered into an amendment to its four-year supply agreement with Twist for the purchase of diverse products including synthetic DNA.”
FILING10-K0001628280-26-012346cik 0001830214
“These decreases were partially offset by an increase of $7.6 million in information technology expenses primarily due to a shortfall in contractually committed spending related to our strategic cloud and AI partnership with Google Cloud (see Note 12 of our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K for further details).”
FILING10-K0001628280-26-012346cik 0001830214
“These decreases were partially offset by the recognition of $7.5 million in non-cash revenue from the release of a deferred revenue balance associated with the terminated BiomEdit, Inc. ("BiomEdit") contract in 2025 (see Note 17 of our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K for further details) and an increase in revenue related to programs with large enterprise customers primarily in the pharmaceutical and biotechnology industries and with the U.S. government (healthcare and defense sectors).”
FILING10-K0001628280-26-012346cik 0001830214
“We are currently offering biomonitoring and bioinformatics support services domestically through our partnerships with the CDC and XpresCheck, and internationally.”
FILING10-K0001628280-26-012346cik 0001830214
“We are currently offering biomonitoring and bioinformatics support services domestically through our partnerships with the CDC and XpresCheck, and internationally.”
FILING10-K0001628280-26-012346cik 0001830214
“These offerings are supported by easy-to-access fee-for-service programs, including our collaboration with Virica Biotech for AAV manufacturing optimization.”
FILING10-K0001628280-26-012346cik 0001830214
Watchlist prices, news filtered to it, and its next report on your desk.
Ginkgo Bioworks Holdings, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Biological Products, (No Diagnostic Substances)
Ginkgo Bioworks Holdings, Inc. has 3 disclosed suppliers and 3 disclosed customers. Each one is named in an SEC filing, either Ginkgo Bioworks Holdings, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
DNA (Ginkgo Bioworks Holdings, Inc.) has 3 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: TWST +2.26%, in healthcare.